Lv1
90 积分 2022-09-05 加入
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
15天前
已完结
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
15天前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1个月前
已完结
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages
1个月前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
2个月前
已完结
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages
2个月前
已完结
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
3个月前
已完结
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
3个月前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
3个月前
已完结
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future
4个月前
已完结
皖公网安备34019202002308
